Literature DB >> 15118546

Clinical course and flow cytometric analysis of paroxysmal nocturnal hemoglobinuria in the United States and Japan.

Jun-Ichi Nishimura1, Yuzuru Kanakura, Russell E Ware, Tsutomu Shichishima, Hideki Nakakuma, Haruhiko Ninomiya, Carlos M Decastro, Sharon Hall, Akihisa Kanamaru, Keith M Sullivan, Hideaki Mizoguchi, Mitsuhiro Omine, Taroh Kinoshita, Wendell F Rosse.   

Abstract

: To determine and directly compare the clinical course of white and Asian patients with paroxysmal nocturnal hemoglobinuria (PNH), data were collected for epidemiologic analysis on 176 patients from Duke University and 209 patients from Japan. White patients were younger with significantly more classical symptoms of PNH including thrombosis, hemoglobinuria, and infection, while Asian patients were older with more marrow aplasia. The mean fraction of CD59-negative polymorphonuclear cells (PMN) at initial analysis was higher among Duke patients than Japanese patients. In both cohorts, however, a larger PNH clone was associated with classical PNH symptoms, while a smaller PNH clone was associated with marrow aplasia. Thrombosis was significantly more prevalent in white patients than Asian patients, and was associated with a significantly higher proportion of CD59-negative PMN. For individual patients, CD59-negative populations varied considerably over time, but a decreasing PNH clone portended hematopoietic failure. Survival analysis revealed a similar death rate in each group, although causes of death were different and significantly more Duke patients died from thrombosis. Japanese patients had a longer mean survival time (32.1 yr vs. 19.4 yr), although Kaplan-Meier survival curves were not significantly different. Poor survival in both groups was associated with age over 50 years, severe leukopenia/neutropenia at diagnosis, and severe infection as a complication; additionally, thrombosis at diagnosis or follow-up for Duke patients and renal failure for Japanese patients were poor prognostic factors. These data identify important differences between white and Asian patients with PNH. Identification of prognostic factors will help the design of prospective clinical trials for PNH.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15118546     DOI: 10.1097/01.md.0000126763.68170.46

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.889


  65 in total

1.  Paroxysmal nocturnal hemoglobinuria and eculizumab.

Authors:  Lucio Luzzatto; Antonio Maria Risitano; Rosario Notaro
Journal:  Haematologica       Date:  2010-04       Impact factor: 9.941

Review 2.  Stem cell transplantation for paroxysmal nocturnal hemoglobinuria.

Authors:  Robert A Brodsky
Journal:  Haematologica       Date:  2010-06       Impact factor: 9.941

Review 3.  New insights into molecular pathogenesis of bone marrow failure in paroxysmal nocturnal hemoglobinuria.

Authors:  Tatsuya Kawaguchi; Hideki Nakakuma
Journal:  Int J Hematol       Date:  2007-07       Impact factor: 2.490

Review 4.  Diagnosis and management of paroxysmal nocturnal hemoglobinuria.

Authors:  Charles Parker; Mitsuhiro Omine; Stephen Richards; Jun-Ichi Nishimura; Monica Bessler; Russell Ware; Peter Hillmen; Lucio Luzzatto; Neal Young; Taroh Kinoshita; Wendell Rosse; Gerard Socié
Journal:  Blood       Date:  2005-07-28       Impact factor: 22.113

5.  Paroxysmal nocturnal hemoglobinuria.

Authors:  Mitsuhiro Omine; Taroh Kinoshita; Hideki Nakakuma; Jaroslaw P Maciejewski; Charles J Parker; Gérard Socié
Journal:  Int J Hematol       Date:  2005-12       Impact factor: 2.490

6.  A comparative analysis of clinical characteristics of patients with paroxysmal nocturnal hemoglobinuria between Asia and Europe/America.

Authors:  Fan Yu; Yali Du; Bing Han
Journal:  Int J Hematol       Date:  2016-04-08       Impact factor: 2.490

Review 7.  Paroxysmal nocturnal haemoglobinuria.

Authors:  Anita Hill; Amy E DeZern; Taroh Kinoshita; Robert A Brodsky
Journal:  Nat Rev Dis Primers       Date:  2017-05-18       Impact factor: 52.329

8.  Increased soluble urokinase plasminogen activator receptor (suPAR) is associated with thrombosis and inhibition of plasmin generation in paroxysmal nocturnal hemoglobinuria (PNH) patients.

Authors:  Elaine M Sloand; Loretta Pfannes; Phillip Scheinberg; Kenneth More; Colin O Wu; McDonald Horne; Neal S Young
Journal:  Exp Hematol       Date:  2008-10-26       Impact factor: 3.084

9.  Microvascular thrombosis in the hepatic vein of a patient with paroxysmal nocturnal hemoglobinuria.

Authors:  Hideyoshi Noji; Tsutomu Shichishima; Masatoshi Okamoto; Akiko Shichishima-Nakamura; Hayato Matsumoto; Hiroko Tajima; Kazuei Ogawa; Yukio Maruyama
Journal:  Int J Hematol       Date:  2007-10       Impact factor: 2.490

Review 10.  Successful anticoagulant therapy for two pregnant PNH patients, and prospects for the eculizumab era.

Authors:  Yasuyoshi Morita; Jun-ichi Nishimura; Takahiro Shimada; Hirokazu Tanaka; Kentaro Serizawa; Yasuhiro Taniguchi; Mitsuhiro Tsuritani; Yuzuru Kanakura; Itaru Matsumura
Journal:  Int J Hematol       Date:  2013-03-02       Impact factor: 2.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.